...Thousand Oaks, Calif.). In the same period, the company also acquired chemical ligation technology from Gryphon...
...limits to the size of peptides that can be made this way. This is where Gryphon's...
...created with Gryphon technology, but the concept allows us to think about how to use Gryphon's...

...director; Hired: Friedhelm Blobel as president, CEO and a director, formerly president and CEO of Gryphon Therapeutics Inc. WIR...

...June 2. He was most recently president, CEO and a director of protein therapeutics company Gryphon...

...on the call that it had acquired the chemical ligation technology and associated IP from Gryphon...
...not disclosed. Amgen Inc. (AMGN), Thousand Oaks, Calif. Amylin Pharmaceuticals Inc. (AMLN), San Diego, Calif. Gryphon...

...administration. In addition to CERA, ROCZ has a play on synthetic erythropoiesis protein (SEP) from Gryphon...

...Ph III for ovarian cancer. 3/25/02 Gryphon Hematology Preclinical Received an exclusive global license to Gryphon's...

...Roche (SWX:ROCZ, Basel, Switzerland) has an exclusive license to SEP (see BioCentury, April 22, 2002). Gryphon...

...by HealthCare Ventures; Advent Venture Partners; and Merrill Lynch Ventures. Other investors included Prolog Ventures; Gryphon...

...HealthCare Ventures VI; Advent Venture Partners; and Merrill Lynch Ventures. Other investors included Prolog Ventures; Gryphon...